Precision Wealth Strategies LLC Acquires New Stake in Aspen Aerogels, Inc. (NYSE:ASPN)

Precision Wealth Strategies LLC acquired a new stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 12,551 shares of the construction company’s stock, valued at approximately $348,000.

Other hedge funds also recently bought and sold shares of the company. Banque Cantonale Vaudoise increased its position in Aspen Aerogels by 37.5% during the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock valued at $81,000 after acquiring an additional 1,252 shares during the last quarter. Point72 Hong Kong Ltd bought a new stake in Aspen Aerogels during the second quarter valued at about $84,000. nVerses Capital LLC bought a new stake in Aspen Aerogels during the second quarter valued at about $95,000. Quent Capital LLC bought a new stake in Aspen Aerogels during the third quarter valued at about $118,000. Finally, Point72 DIFC Ltd bought a new stake in Aspen Aerogels during the second quarter valued at about $121,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

ASPN has been the subject of several recent research reports. Roth Mkm reissued a “buy” rating and set a $36.00 price target on shares of Aspen Aerogels in a report on Wednesday, August 21st. TD Cowen upped their price objective on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research note on Tuesday, August 20th. Benchmark reaffirmed a “buy” rating and issued a $14.00 price objective on shares of Aspen Aerogels in a research note on Thursday, August 8th. B. Riley raised Aspen Aerogels to a “strong-buy” rating in a research note on Tuesday, June 25th. Finally, Barclays started coverage on Aspen Aerogels in a research note on Tuesday, August 6th. They issued an “overweight” rating and a $27.00 price objective for the company. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $29.70.

Insider Transactions at Aspen Aerogels

In other news, CEO Donald R. Young sold 63,355 shares of the stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the sale, the chief executive officer now directly owns 483,640 shares in the company, valued at approximately $14,523,709.20. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at $626,610.60. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction on Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the transaction, the chief executive officer now owns 483,640 shares in the company, valued at $14,523,709.20. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 4.30% of the company’s stock.

Aspen Aerogels Trading Down 1.3 %

Shares of ASPN stock opened at $21.33 on Tuesday. Aspen Aerogels, Inc. has a 1 year low of $6.62 and a 1 year high of $33.15. The company has a debt-to-equity ratio of 0.23, a current ratio of 3.46 and a quick ratio of 2.82. The stock’s 50 day simple moving average is $25.96 and its two-hundred day simple moving average is $24.48. The company has a market cap of $1.62 billion, a PE ratio of -48.48 and a beta of 2.16.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Wednesday, August 7th. The construction company reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.16. Aspen Aerogels had a return on equity of 0.74% and a net margin of 0.39%. The business had revenue of $117.80 million for the quarter, compared to the consensus estimate of $101.99 million. During the same period in the prior year, the business posted ($0.22) earnings per share. The company’s quarterly revenue was up 144.4% compared to the same quarter last year. Research analysts predict that Aspen Aerogels, Inc. will post 0.21 earnings per share for the current year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.